A Phase 2 of ELX-02 in Cystinosis patients carrying non-sense mutations
Phase of Trial: Phase II
Latest Information Update: 19 Mar 2018
At a glance
- Drugs ELX 02 (Primary)
- Indications Cystinosis
- Focus Therapeutic Use
- Sponsors Eloxx Pharmaceuticals
- 19 Mar 2018 According to an Eloxx Pharmaceuticals media release, the company expect to initiate this study by end of 2018.
- 04 Aug 2017 New trial record
- 02 Aug 2017 According to an Eloxx Pharmaceuticals media release, the company is planning to initiate this trial later in 2017.